275 related articles for article (PubMed ID: 19047026)
41. [Use of the EvalObs
Girerd X; Hanon O; Vaïsse B
Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508
[TBL] [Abstract][Full Text] [Related]
42. Alcohol screening results in elderly male veterans: association with health status and mortality.
Bridevaux IP; Bradley KA; Bryson CL; McDonell MB; Fihn SD
J Am Geriatr Soc; 2004 Sep; 52(9):1510-7. PubMed ID: 15341553
[TBL] [Abstract][Full Text] [Related]
43. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
[TBL] [Abstract][Full Text] [Related]
44. Alcohol misuse and multiple sclerosis.
Turner AP; Hawkins EJ; Haselkorn JK; Kivlahan DR
Arch Phys Med Rehabil; 2009 May; 90(5):842-8. PubMed ID: 19406306
[TBL] [Abstract][Full Text] [Related]
45. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
Zweben A; Piepmeier ME; Fucito L; O'Malley SS
J Subst Abuse Treat; 2017 Jun; 77():72-78. PubMed ID: 28476276
[TBL] [Abstract][Full Text] [Related]
46. Wide clinic-level variation in adherence to oral diabetes medications in the VA.
Bryson CL; Au DH; Maciejewski ML; Piette JD; Fihn SD; Jackson GL; Perkins M; Wong ES; Yano EM; Liu CF
J Gen Intern Med; 2013 May; 28(5):698-705. PubMed ID: 23371383
[TBL] [Abstract][Full Text] [Related]
47. Readiness to change in primary care patients who screened positive for alcohol misuse.
Williams EC; Kivlahan DR; Saitz R; Merrill JO; Achtmeyer CE; McCormick KA; Bradley KA
Ann Fam Med; 2006; 4(3):213-20. PubMed ID: 16735522
[TBL] [Abstract][Full Text] [Related]
48. Alcohol screening scores and the risk of intensive care unit admission and hospital readmission.
Clark BJ; Rubinsky AD; Ho PM; Au DH; Chavez LJ; Moss M; Bradley KA
Subst Abus; 2016; 37(3):466-473. PubMed ID: 26730984
[TBL] [Abstract][Full Text] [Related]
49. Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study.
Marcum ZA; Walker RL; Jones BL; Ramaprasan A; Gray SL; Dublin S; Crane PK; Larson EB
BMC Geriatr; 2019 Feb; 19(1):41. PubMed ID: 30764775
[TBL] [Abstract][Full Text] [Related]
50. Measures of adherence to oral hypoglycemic agents at the primary care clinic level: the role of risk adjustment.
Wong ES; Piette JD; Liu CF; Perkins M; Maciejewski ML; Jackson GL; Blough DK; Fihn SD; Au DH; Bryson CL
Med Care; 2012 Jul; 50(7):591-8. PubMed ID: 22354208
[TBL] [Abstract][Full Text] [Related]
51. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
[TBL] [Abstract][Full Text] [Related]
52. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
53. Prescriber continuity and medication adherence for complex patients.
Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML
Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627
[TBL] [Abstract][Full Text] [Related]
54. Antihypertensive medication adherence in the Department of Veterans Affairs.
Siegel D; Lopez J; Meier J
Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
[TBL] [Abstract][Full Text] [Related]
55. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
Patel P; Gupta P; Burns A; Suwaidan AA; Cole R; Lane D; Seidu S; Khunti K
Diabetes Care; 2019 Jun; 42(6):1132-1135. PubMed ID: 30885952
[TBL] [Abstract][Full Text] [Related]
56. Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis.
Lauffenburger JC; Gagne JJ; Song Z; Brill G; Choudhry NK
BMJ Open; 2016 Aug; 6(8):e010958. PubMed ID: 27491664
[TBL] [Abstract][Full Text] [Related]
57. The effect of a locally adapted, secondary stroke risk factor self-management program on medication adherence among veterans with stroke/TIA.
Damush TM; Myers L; Anderson JA; Yu Z; Ofner S; Nicholas G; Kimmel B; Schmid AA; Kent T; Williams LS
Transl Behav Med; 2016 Sep; 6(3):457-68. PubMed ID: 27349906
[TBL] [Abstract][Full Text] [Related]
58. Somatic symptoms of anxiety and nonadherence to statin therapy.
Korhonen MJ; Pentti J; Hartikainen J; Kivimäki M; Vahtera J
Int J Cardiol; 2016 Jul; 214():493-9. PubMed ID: 27100341
[TBL] [Abstract][Full Text] [Related]
59. Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls.
Braithwaite RS; Conigliaro J; McGinnis KA; Maisto SA; Bryant K; Justice AC
Alcohol Clin Exp Res; 2008 Sep; 32(9):1645-51. PubMed ID: 18616666
[TBL] [Abstract][Full Text] [Related]
60. The impact of an appointment-based medication synchronization programme on chronic medication adherence in an adult community pharmacy population.
Andrews SB; Marcy TR; Osborn B; Planas LG
J Clin Pharm Ther; 2017 Aug; 42(4):461-466. PubMed ID: 28439911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
